Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
M&A / Property Routine +

Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec

Cannabix Technologies Inc.

By The Northwire Desk — AI Analysis Jun 15, 2026 · 08:45 BLO · 0.6 Cannabix Technologies Inc.
Executive Summary
  • Cannabix Technologies announced the deployment of its Marijuana Breath Test (MBT) system with a major heavy materials industrial operator in Quebec.
  • The deployment was facilitated through partner Alco Prevention Canada and targets post-incident and reasonable-cause workplace safety protocols.
  • The release emphasizes the industry shift toward breath-based THC detection as a non-invasive, recent-use assessment tool that avoids the legal and operational ambiguities of traditional urine or oral fluid testing.
  • No specific contract value, unit volume, or revenue contribution was disclosed.
Material Impact
  • The announcement represents incremental commercial progress within the company's phased rollout strategy, consistent with prior deployments in Virginia (April), construction (March), and clinical settings (May).
  • Given the company's current revenue scale ($123k CAD over six months) and the undisclosed nature of the contract, the immediate financial impact is negligible.
  • The news does not introduce new regulatory approvals, financing, or strategic partnerships that would alter the capital or commercialization trajectory.
  • Market reaction is likely to be muted, as the stock has already consolidated around $0.60–$0.70 following the March commercial launch spike.
BLO · Price
Company Overview
  • Cannabix Technologies develops breath-based detection technologies for workplace safety and public health.
  • Core products include the Marijuana Breath Test (MBT) for recent THC detection and BreathLogix for unmanned alcohol screening.
  • Target markets are safety-sensitive industries: construction, manufacturing, mining, maritime, transportation, and aviation.
  • Revenue model combines hardware sales (Breath Collection Units) with recurring revenue from disposable breath cartridges.
  • Strategic partnership with Omega Laboratories provides forensic lab analysis and validation support.
Read the original news release →

More from Cannabix Technologies Inc.

Jun 29, 2026 · 08:45

Cannabix scales its breath-based THC and alcohol screening hardware into global mining and industrial sectors, but revenue remains negligible against operating burn.

Production / Operations May 29, 2026 · 08:45

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Production / Operations May 13, 2026 · 08:45

Cannabix Secures UL/CSA Certs, Clears Path for Gov Tenders Amidst Steady Commercial Rollout

Regulatory May 04, 2026 · 08:45

Cannabix Executes Commercial Rollout Amidst Dilution Concerns

Production / Operations Apr 20, 2026 · 08:45

Cannabix Breath Test Gains Traction in US Manufacturing Sector Following Commercial Launch

M&A / Property Apr 01, 2026 · 08:45

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client

Production / Operations